Context:

A high‑level crackdown on Medicare fraud reveals a 7,100% surge in tissue and organ transplant claims over six years, as a White House task force led by Vice President JD Vance and supported by CMS chief Mehmet Oz intensifies enforcement. The effort, spanning 2019–2025, culminates in widespread denials of fraudulent claims and aggressive actions against suppliers, signaling a sustained push to shield vulnerable patients. The initiative, launched by an executive order, coordinates DOJ, HHS, and other agencies to root out corruption and hold bad actors accountable. The outlook emphasizes continued scrutiny and enforcement momentum against fraud across Medicare programs.

Dive Deeper:

• The anti‑fraud push is led by a task force appointed by President Trump, with Vice President JD Vance at the helm and involvement from the DOJ and CMS. The initiative aims to identify and shut down fraudulent schemes targeting elderly and sick beneficiaries, using arrests, convictions, and administrative actions to disrupt schemes.

• Between 2019 and 2025, transplant-related claims rose from $200 million to $14.4 billion, prompting the CMS and the task force to flag potentially fraudulent activity and halt many payments. The agency identified thousands of suspicious allograft claims, totaling hundreds of millions in charges through the current year.

• Durable Medical Equipment (DME) fraud was another focus, with the government suspending payments to dozens of suppliers and revoking billing rights for hundreds more. Officials described a moratorium on new DME companies and aggressive enforcement as central to curbing this fraud stream.

• Officials cited a notable impact in Medicare funding: a portion of DME payments tied to suspected fraud represented a sizable share of 2025 funding, underscoring the scale of the challenge and the reach of the enforcement effort.

• A spokesperson for Vance’s office claimed that the recent measures have effectively ended a significant wave of fraud in the DME sector within months, highlighting the collaboration among the White House, DOJ, and HHS as critical to the success.

• Public briefings and events featured Oz and Vance presenting the results of the crackdown, with future plans indicating ongoing investigations and further actions to deter and punish fraud across Medicaid and Medicare programs.